JP2024531238A5 - - Google Patents

Info

Publication number
JP2024531238A5
JP2024531238A5 JP2024508686A JP2024508686A JP2024531238A5 JP 2024531238 A5 JP2024531238 A5 JP 2024531238A5 JP 2024508686 A JP2024508686 A JP 2024508686A JP 2024508686 A JP2024508686 A JP 2024508686A JP 2024531238 A5 JP2024531238 A5 JP 2024531238A5
Authority
JP
Japan
Application number
JP2024508686A
Other languages
Japanese (ja)
Other versions
JPWO2023018891A5 (https=
JP2024531238A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/040092 external-priority patent/WO2023018891A1/en
Publication of JP2024531238A publication Critical patent/JP2024531238A/ja
Publication of JPWO2023018891A5 publication Critical patent/JPWO2023018891A5/ja
Publication of JP2024531238A5 publication Critical patent/JP2024531238A5/ja
Pending legal-status Critical Current

Links

JP2024508686A 2021-08-12 2022-08-11 がんを処置するための方法および組成物 Pending JP2024531238A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163232409P 2021-08-12 2021-08-12
US63/232,409 2021-08-12
PCT/US2022/040092 WO2023018891A1 (en) 2021-08-12 2022-08-11 Methods and compositions for treating cancer

Publications (3)

Publication Number Publication Date
JP2024531238A JP2024531238A (ja) 2024-08-29
JPWO2023018891A5 JPWO2023018891A5 (https=) 2025-08-19
JP2024531238A5 true JP2024531238A5 (https=) 2025-08-19

Family

ID=85200519

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024508686A Pending JP2024531238A (ja) 2021-08-12 2022-08-11 がんを処置するための方法および組成物

Country Status (11)

Country Link
US (1) US20240299326A1 (https=)
EP (1) EP4384498A1 (https=)
JP (1) JP2024531238A (https=)
CN (1) CN118076583A (https=)
AU (1) AU2022326485A1 (https=)
CA (1) CA3228644A1 (https=)
CO (1) CO2024002786A2 (https=)
GB (1) GB2628229A (https=)
IL (1) IL310759A (https=)
MX (1) MX2024001935A (https=)
WO (1) WO2023018891A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5156389B2 (ja) * 2005-01-05 2013-03-06 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション 薬剤耐性増殖性疾患の治療剤
WO2014089483A1 (en) * 2012-12-07 2014-06-12 Onconova Therapeutics, Inc. Methods and compositions for treatment of cancer
JP2018530590A (ja) * 2015-10-14 2018-10-18 タリックス ファーマシューティカルズ リミテッド 表皮水疱症の処置のための方法及び組成物
CA3076610A1 (en) * 2017-09-22 2019-03-28 University Of Miami Methods and compositions for the treatment of epidermolysis bullosa

Similar Documents

Publication Publication Date Title
JP2024531238A5 (https=)
CL2026000149A1 (es) Vacuna contra el rsv.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307048517S (https=)
BY13140U (https=)
BY13155U (https=)
CN307048033S (https=)
CN307047609S (https=)
BY13153U (https=)
BY13152U (https=)
CN307047067S (https=)
BY13151U (https=)
BY13150U (https=)
BY13149U (https=)
BY13145U (https=)